Sussex Formulary

Drug Status Key

  • Non-Specialist Drugs
  • Specialist recommendation (or initiation where noted)
  • Specialist Initiation WITH Shared Care Guidelines
  • Specialist ONLY Drugs
  • Mixed Status - See individual drug entries for more details

Preferences

  • First Line
  • Second Line
  • Third Line
  • No Preference

Aldesleukin

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Bacillus Calmette-Guerin

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Belumosudil

Black Triangle { Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

For treating chronic graft-versus-host disease in people 12 years and over after 2 or more systemic treatments (NICE TA949).

Belumosudil 200mg tablets

Pack
30 tablet

Ivosidenib

Black Triangle { Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

For the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an IDH1 R132 mutation who were previously treated by at least one prior line of systemic therapy NICE TA948

For untreated acute myeloid leukaemia (AML) with an IDH1 R132 mutation in adults who cannot have standard intensive induction chemotherapy. NICE TA979

Ivosidenib 250mg tablets

Pack
60 tablet

Lenalidomide

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Lisocabtagene maraleucel

Black Triangle { Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Mifamurtide

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Pomalidomide

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Talimogene laherparepvec

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Thalidomide

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }

Thalidomide 25mg tablets

Pack
100 tablet
1 tablet
30 tablet

Thalidomide 100mg tablets

Pack
30 tablet
100 tablet
1 tablet

Thalidomide 50mg capsules

Pack
28 capsule

Serplulimab

{ Value = NICE, Index = 0 } { Value = EMC, Index = 3 }